Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases

Carlo Greco, Michael J. Zelefsky, Michael Lovelock, Zvi Fuks, Margie Hunt, Kenneth Rosenzweig, Joan Zatcky, Balem Kim, Yoshiya Yamada

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Abstract

Purpose: To report tumor local control after treatment with single-dose image-guided intensity-modulated radiotherapy (SD-IGRT) to extracranial metastatic sites. Methods and Materials: A total of 126 metastases in 103 patients were treated with SD-IGRT to prescription doses of 18-24 Gy (median, 24 Gy) between 2004 and 2007. Results: The overall actuarial local relapse-free survival (LRFS) rate was 64% at a median follow-up of 18 months (range, 2-45 months). The median time to failure was 9.6 months (range, 1-23 months). On univariate analysis, LRFS was significantly correlated with prescription dose (p = 0.029). Stratification by dose into high (23 to 24 Gy), intermediate (21 to 22 Gy), and low (18 to 20 Gy) dose levels revealed highly significant differences in LRFS between high (82%) and low doses (25%) (p < 0.0001). Overall, histology had no significant effect on LRFS (p = 0.16). Renal cell histology displayed a profound dose-response effect, with 80% LRFS at the high dose level (23 to 24 Gy) vs. 37% with low doses (≤22 Gy) (p = 0.04). However, for patients who received the high dose level, histology was not a statistically significant predictor of LRFS (p = 0.90). Target organ (bone vs. lymph node vs. soft tissues) (p = 0.5) and planning target volume size (p = 0.55) were not found to be associated with long-term LRFS probability. Multivariate Cox regression analysis confirmed prescription dose to be a significant predictor of LRFS (p = 0.003). Conclusion: High-dose SD-IGRT is a noninvasive procedure resulting in high probability of local tumor control. Single-dose IGRT may be effectively used to locally control metastatic deposits regardless of histology and target organ, provided sufficiently high doses (> 22 Gy) of radiation are delivered.

Original languageEnglish
Pages (from-to)1151-1157
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume79
Issue number4
DOIs
StatePublished - 15 Mar 2011
Externally publishedYes

Keywords

  • IMRT
  • Image-guided radiotherapy
  • Metastases
  • Single fraction

Fingerprint

Dive into the research topics of 'Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases'. Together they form a unique fingerprint.

Cite this